Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Bio Cryst Pharmaceuticals Appoints Dr. Donald S. Fong As Chief Medical Officer

PUBLIC · BCRXSep 05, 2024•almost 2 years ago

Position

Chief Medical Officer

Company

BioCryst Pharmaceuticals

Donald S. Fong

DurhamBiotechnologyHealth CareTherapeutics

Description

BioCryst Pharmaceuticals, Inc has announced the appointment of Dr. Donald S. Fong as the company's new chief medical officer

Company Information

Company

BioCryst Pharmaceuticals

Location

Durham, North Carolina, United States

About

BioCryst is focused on developing novel therapies for diseases with significant unmet needs. The company has already commercialized ORLADEYO® (berotralstat), a once-daily oral plasma kallikrein inhibitor, and continues to develop a pipeline of small-molecule and protein therapies.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for BioCryst Pharmaceuticals's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months